SPY331.71+1.65 0.50%
DIA271.15+2.74 1.02%
IXIC10,976.07+34.90 0.32%

Hearing Citi Out Positive On Karuna Therapeutics, Has $115 Price Target, Representing 51% Upside From Current Price

Benzinga · -